#$%^&*AU2020210145A120200813.pdf#####COMBINATION OF AN OX40 AGONIST AND A 4-1BB AGONIST FOR TREATING CANCER Abstract The present disclosure describes combination therapies comprising an agonist of OX40 and an agonist of 4-1BB, and the use of the combination therapies for the treatment of cancer.